Matthews C - Search Results

1

The disposition and metabolism of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in human subjects.

Halpin RA, Porras AG, Geer LA, Davis MR, Cui D, Doss GA, Woolf E, Musson D, Matthews C, Mazenko R, Schwartz JI, Lasseter KC, Vyas KP, Baillie TA. Halpin RA, et al. Among authors: matthews c. Drug Metab Dispos. 2002 Jun;30(6):684-93. doi: 10.1124/dmd.30.6.684. Drug Metab Dispos. 2002. PMID: 12019196

2

Absorption, metabolism, and excretion of etoricoxib, a potent and selective cyclooxygenase-2 inhibitor, in healthy male volunteers.

Rodrigues AD, Halpin RA, Geer LA, Cui D, Woolf EJ, Matthews CZ, Gottesdiener KM, Larson PJ, Lasseter KC, Agrawal NG. Rodrigues AD, et al. Among authors: matthews cz. Drug Metab Dispos. 2003 Feb;31(2):224-32. doi: 10.1124/dmd.31.2.224. Drug Metab Dispos. 2003. PMID: 12527704

3

Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man.

Agrawal NG, Porras AG, Matthews CZ, Rose MJ, Woolf EJ, Musser BJ, Dynder AL, Mazina KE, Lasseter KC, Hunt TL, Schwartz JI, McCrea JB, Gottesdiener KM. Agrawal NG, et al. Among authors: matthews cz. J Clin Pharmacol. 2003 Mar;43(3):268-76. doi: 10.1177/0091270003251122. J Clin Pharmacol. 2003. PMID: 12638395 Clinical Trial.

4

Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers.

Agrawal NG, Porras AG, Matthews CZ, Woolf EJ, Miller JL, Mukhopadhyay S, Neu DC, Gottesdiener KM. Agrawal NG, et al. Among authors: matthews cz. J Clin Pharmacol. 2001 Oct;41(10):1106-10. doi: 10.1177/00912700122012715. J Clin Pharmacol. 2001. PMID: 11583479 Clinical Trial.

5

Pharmacokinetics of etoricoxib in patients with hepatic impairment.

Agrawal NG, Rose MJ, Matthews CZ, Woolf EJ, Porras AG, Geer LA, Larson PJ, Cote J, Dilzer SC, Lasseter KC, Alam I, Petty KJ, Gottesdiener KM. Agrawal NG, et al. Among authors: matthews cz. J Clin Pharmacol. 2003 Oct;43(10):1136-48. doi: 10.1177/0091270003257219. J Clin Pharmacol. 2003. PMID: 14517196 Clinical Trial.

6

Pharmacokinetics of etoricoxib in patients with renal impairment.

Agrawal NG, Matthews CZ, Mazenko RS, Kline WF, Woolf EJ, Porras AG, Geer LA, Wong PH, Cho M, Cote J, Marbury TC, Moncrief JW, Alcorn H Jr, Swan S, Sack MR, Robson RA, Petty KJ, Schwartz JI, Gottesdiener KM. Agrawal NG, et al. Among authors: matthews cz. J Clin Pharmacol. 2004 Jan;44(1):48-58. doi: 10.1177/0091270003260338. J Clin Pharmacol. 2004. PMID: 14681341

7

Determination of a novel gamma-secretase inhibitor in human plasma and cerebrospinal fluid using automated 96 well solid phase extraction and liquid chromatography/tandem mass spectrometry.

Matthews CZ, Woolf EJ. Matthews CZ, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Feb 15;863(1):36-45. doi: 10.1016/j.jchromb.2007.12.025. Epub 2008 Jan 6. J Chromatogr B Analyt Technol Biomed Life Sci. 2008. PMID: 18249589

8

High-throughput, semi-automated determination of a cyclooxygenase II inhibitor in human plasma and urine using solid-phase extraction in the 96-well format and high-performance liquid chromatography with post-column photochemical derivatization-fluorescence detection.

Matthews CZ, Woolf EJ, Lin L, Fang W, Hsieh J, Ha S, Simpson R, Matuszewski BK. Matthews CZ, et al. J Chromatogr B Biomed Sci Appl. 2001 Feb 25;751(2):237-46. doi: 10.1016/s0378-4347(00)00475-8. J Chromatogr B Biomed Sci Appl. 2001. PMID: 11236079

9

Improved procedure for the the determination of rofecoxib in human plasma involving 96-well solid-phase extraction and fluorescence detection.

Matthews CZ, Woolf EJ, Matuszewski BK. Matthews CZ, et al. J Chromatogr A. 2002 Mar 8;949(1-2):83-9. doi: 10.1016/s0021-9673(01)01221-3. J Chromatogr A. 2002. PMID: 11999761

10

Determination of efavirenz, a selective non-nucleoside reverse transcriptase inhibitor, in human plasma using HPLC with post-column photochemical derivatization and fluorescence detection.

Matthews CZ, Woolf EJ, Mazenko RS, Haddix-Wiener H, Chavez-Eng CM, Constanzer ML, Doss GA, Matuszewski BK. Matthews CZ, et al. J Pharm Biomed Anal. 2002 Jun 1;28(5):925-34. doi: 10.1016/s0731-7085(01)00709-9. J Pharm Biomed Anal. 2002. PMID: 12039635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,452 results

Search Page

Filters